CA1327005C - Nucleosides therapeutiques - Google Patents

Nucleosides therapeutiques

Info

Publication number
CA1327005C
CA1327005C CA000616147A CA616147A CA1327005C CA 1327005 C CA1327005 C CA 1327005C CA 000616147 A CA000616147 A CA 000616147A CA 616147 A CA616147 A CA 616147A CA 1327005 C CA1327005 C CA 1327005C
Authority
CA
Canada
Prior art keywords
prophylaxis
treatment
virus infection
hepatitis
dideoxyguanosine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA000616147A
Other languages
English (en)
Inventor
George Walter Koszalka
Thomas Anthony Krenitsky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858512330A external-priority patent/GB8512330D0/en
Priority claimed from GB868604239A external-priority patent/GB8604239D0/en
Priority claimed from CA000509129A external-priority patent/CA1314875C/fr
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Priority to CA000616147A priority Critical patent/CA1327005C/fr
Application granted granted Critical
Publication of CA1327005C publication Critical patent/CA1327005C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA000616147A 1985-05-15 1991-08-26 Nucleosides therapeutiques Expired - Fee Related CA1327005C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA000616147A CA1327005C (fr) 1985-05-15 1991-08-26 Nucleosides therapeutiques

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB858512330A GB8512330D0 (en) 1985-05-15 1985-05-15 Antiviral compounds
GB8512330 1985-05-15
GB868604239A GB8604239D0 (en) 1986-02-20 1986-02-20 Antiviral compounds
GB8604239 1986-02-20
CA000509129A CA1314875C (fr) 1985-05-15 1986-05-14 Nucleosides therapeutiques
CA000616147A CA1327005C (fr) 1985-05-15 1991-08-26 Nucleosides therapeutiques

Publications (1)

Publication Number Publication Date
CA1327005C true CA1327005C (fr) 1994-02-15

Family

ID=27167603

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000616147A Expired - Fee Related CA1327005C (fr) 1985-05-15 1991-08-26 Nucleosides therapeutiques

Country Status (1)

Country Link
CA (1) CA1327005C (fr)

Similar Documents

Publication Publication Date Title
EP0206497B1 (fr) Nucléosides thérapeutiques et leur préparation
EP0291633B1 (fr) Utilisation de la 3'azido-3'-déoxythymidine pour le traitement ou la prophylaxie des infections humaines à rétrovirus
CA1285935C (fr) Nucleosides therapeutiques
EP0277151B1 (fr) Nouvelle application medicinale de nucleosides
EP0285432B1 (fr) Nucléosides thérapeutiques
US5071983A (en) Therapeutic nucleosides
US4920210A (en) 2,6-diaminopurine-9-β-D-2',3'-dideoxyribofuranoside
EP0317128B1 (fr) Pyrimidine Nucléosides Anti-HIV
EP0306597B1 (fr) Nucléosides antiviraux
CA1327005C (fr) Nucleosides therapeutiques
EP0594224A2 (fr) Nucléosides thérapeutiques
NO881135L (no) Fremgangsmaate for fremstilling av 1-(3-azido-2,3-dideoksy-betad-erytro-pentofuranosyl)-5-metyl-2(1h)-pyrimidinon.
JP2926257B2 (ja) 抗ウイルス性で高い水溶性を持ち且つ安定な結晶性２′，３′‐ジデオキシイノシン・モノ水和物塩、２′，３′‐ジデオキシ‐２′，３′‐ジデヒドロチミジン・モノ水和物塩及び２′，３′‐ジデオキシ‐２′‐フルオロイノシン・ヘミ水和物塩
IE81107B1 (en) Antiviral highly water soluble stable crystalline salts of 2',3'-dideoxyinosine monohydrate 2',3'-dideoxy-2',3'-didehydrothymidine monohydrate and 2',3'-dideoxy-2'-fluoroinosine hemihydrate
WO1988009332A1 (fr) Nucleosides a usage therapeutique
CA1340519C (fr) Nucleosides antiviraux
CA1336821C (fr) Nucleosides pour usage therapeutique
US5175274A (en) Therapeutic nucleosides
CA1303032C (fr) Nucleosides antiviraux
EP0294113A1 (fr) Nucléosides thérapeutiques
WO1988009796A1 (fr) Analogues de nucleosides
IE880210L (en) Antiviral nucleosides
NZ224007A (en) 3'-azido-3'-deoxythymidine derivatives as antiviral agents
IL85096A (en) Use of 3'-azido-3'- deoxythymidine in the treatment of prophylaxis of human retrovirus infection

Legal Events

Date Code Title Description
MKLA Lapsed